EUVIMEDEUVIMED entdecken
Crossref

Drug repurposing of some US FDA-approved drugs using Binding strength Studies for the Treatment of Methicillin-resistant Staphylococcus aureus Infection

Dibakar Roy

Journal of PhytoPharmaceutical and Advanced Chemistry · 2026-04 · 1 (1) · 30-44

DOI: 10.66220/ecsrwe33 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of PhytoPharmaceutical and Advanced Chemistry, 2026-04. Verfasst von Dibakar Roy.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Roy, D. (2026). Drug repurposing of some US FDA-approved drugs using Binding strength Studies for the Treatment of Methicillin-resistant Staphylococcus aureus Infection. Journal of PhytoPharmaceutical and Advanced Chemistry, 1(1), 30-44. https://doi.org/10.66220/ecsrwe33

Vancouver

Roy D. Drug repurposing of some US FDA-approved drugs using Binding strength Studies for the Treatment of Methicillin-resistant Staphylococcus aureus Infection. Journal of PhytoPharmaceutical and Advanced Chemistry. 2026;1(1):30-44. doi:10.66220/ecsrwe33

BibTeX
@article{Roy2026,
  author = {Roy, Dibakar},
  title = {Drug repurposing of some US FDA-approved drugs using Binding strength Studies for the Treatment of Methicillin-resistant Staphylococcus aureus Infection},
  journal = {Journal of PhytoPharmaceutical and Advanced Chemistry},
  year = {2026},
  volume = {1},
  number = {1},
  pages = {30--44},
  doi = {10.66220/ecsrwe33}
}
Kostenlos starten →